People make Genentech what it is.
Read about breakthrough science, the everyday people who make it happen, and the patients we serve.
In 2013, the FDA approved the first medicine under its new, faster Breakthrough Therapy Designation pathway.
We conducted a national survey to learn about the unpredictable symptoms of MS. Here’s what we learned.
Read the stories of people living with diseases or disorders of the kidney including granulomatosis with polyangiitis and lupus nephritis.
Tell us what you think about our company, products, or website.
The true sign of intelligence is not knowledge but imagination.